Clinical Trials in Burlington, Canada
Locations / Burlington, Canada
Delta Trials hosts 397 clinical trials conducted in Burlington, Canada, making it a notable site of clinical research activity. These trials covering 251 medical conditions and multiple therapeutic areas, reflecting the scope and diversity of clinical research in this location. Since 2020, 41 trials in this location have been stopped, mirroring broader trends in global research activity. The trial counts on this page reflect the most recent data ingested from ClinicalTrials.gov, tracking research history across multiple versions for Burlington.
397
Total Trials
251
Conditions
41
Terminated since 2020
Browse by condition (251 total)
- Asthma 37 trialsAll Asthma trials
- Diabetes mellitus, type 2 24 trialsAll Diabetes mellitus, type 2 trials
- Rheumatoid arthritis 17 trialsAll Rheumatoid arthritis trials
- Prostate cancer 16 trialsAll Prostate cancer trials
- Type 2 diabetes mellitus 14 trialsAll Type 2 diabetes mellitus trials
- Pulmonary disease, chronic obstructive 12 trialsAll Pulmonary disease, chronic obstructive trials
- Schizophrenia 12 trialsAll Schizophrenia trials
- Alzheimer's disease 12 trialsAll Alzheimer's disease trials
- Chronic obstructive pulmonary disease 10 trialsAll Chronic obstructive pulmonary disease trials
- All Chronic obstructive pulmonary disease (COPD) trials
- Hypertension 9 trialsAll Hypertension trials
- Atrial fibrillation 8 trialsAll Atrial fibrillation trials
- Cardiovascular disease 8 trialsAll Cardiovascular disease trials
- Diabetes 7 trialsAll Diabetes trials
- Obesity 6 trialsAll Obesity trials
- Arthritis, rheumatoid 6 trialsAll Arthritis, rheumatoid trials
- Type 2 diabetes 6 trialsAll Type 2 diabetes trials
- Heart failure 6 trialsAll Heart failure trials
- Atopic dermatitis 5 trialsAll Atopic dermatitis trials
- Prostatic neoplasms 5 trialsAll Prostatic neoplasms trials